Thursday, May 30, 2019

Lupin#39;s Goa facility may face regulatory action, says USFDA

Lupin#39;s Goa facility may face regulatory action, says USFDA The company has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Goa facility between January 28 to February 8 as Official Action Indicated (OAI), Lupin said in a regulatory filing.

from Moneycontrol Business News http://bit.ly/2Z0UEHU

No comments:

Post a Comment

Equitas Small Finance Bank chief PN Vasudevan plans exit over perceived conflict involving daughter's NBFC

PN Vasudevan's recent announcement of his resignation as managing director of Equitas Small Finance Bank highlights pressing concerns ov...